Clinical Trial Update: Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intravenous CTLA4Ig treatment in recent-onset Type 1 Diabetes Mellitus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• CTLA4-Ig (abatacept or CTLA4-Ig)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2016-08-16